WO2002026930A3 - Acides nucleiques, proteines et anticorps - Google Patents

Acides nucleiques, proteines et anticorps Download PDF

Info

Publication number
WO2002026930A3
WO2002026930A3 PCT/US2001/029838 US0129838W WO0226930A3 WO 2002026930 A3 WO2002026930 A3 WO 2002026930A3 US 0129838 W US0129838 W US 0129838W WO 0226930 A3 WO0226930 A3 WO 0226930A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
antibodies
methods
further relates
present
Prior art date
Application number
PCT/US2001/029838
Other languages
English (en)
Other versions
WO2002026930A9 (fr
WO2002026930A2 (fr
Inventor
Craig A Rosen
Charles E Birse
Original Assignee
Human Genome Sciences Inc
Craig A Rosen
Charles E Birse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, Craig A Rosen, Charles E Birse filed Critical Human Genome Sciences Inc
Priority to AU2001296301A priority Critical patent/AU2001296301A1/en
Priority to AU2001296301A priority patent/AU2001296301A8/xx
Publication of WO2002026930A2 publication Critical patent/WO2002026930A2/fr
Publication of WO2002026930A9 publication Critical patent/WO2002026930A9/fr
Publication of WO2002026930A3 publication Critical patent/WO2002026930A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne de nouvelles protéines, et plus particulièrement, des molécules d'acide nucléique isolées codantes pour de nouveaux polypeptides. Cette invention concerne aussi de nouveaux polypeptides et des anticorps qui se lient à ces polypeptides. Cette invention concerne encore des vecteurs, des cellules hôtes et des techniques de recombinaison et de synthèse permettant de produire des polynucléotides et/ou des polypeptides humains, et des anticorps. Cette invention concerne aussi des techniques diagnostiques et thérapeutiques qui conviennent pour le diagnostic, le traitement, la prévention et/ou le pronostic de pathologies liées à ces nouveaux polypeptides. Cette invention concerne enfin des techniques de criblage permettant d'identifier des agonistes et des antagonistes des ces polynucléotides et de ces polypeptides, et des techniques et/ou des compositions destinées à inhiber ou renforcer la production et la fonction de ces polypeptides.
PCT/US2001/029838 2000-09-26 2001-09-25 Acides nucleiques, proteines et anticorps WO2002026930A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001296301A AU2001296301A1 (en) 2000-09-26 2001-09-25 Nucleic acids, proteins, and antibodies
AU2001296301A AU2001296301A8 (en) 2000-09-26 2001-09-25 Nucleic acids, proteins, and antibodies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23548400P 2000-09-26 2000-09-26
US60/235,484 2000-09-26

Publications (3)

Publication Number Publication Date
WO2002026930A2 WO2002026930A2 (fr) 2002-04-04
WO2002026930A9 WO2002026930A9 (fr) 2005-04-07
WO2002026930A3 true WO2002026930A3 (fr) 2009-06-11

Family

ID=22885694

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/029838 WO2002026930A2 (fr) 2000-09-26 2001-09-25 Acides nucleiques, proteines et anticorps

Country Status (2)

Country Link
AU (2) AU2001296301A8 (fr)
WO (1) WO2002026930A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1102848B1 (fr) 1998-08-07 2010-10-13 Immunex Corporation Molecules designees ldcam
WO2003104275A2 (fr) * 2002-06-06 2003-12-18 Oncotherapy Science, Inc. Genes et polypeptides en rapport avec les cancers du colon chez l'homme
MXPA06000974A (es) 2003-07-25 2006-08-31 Amgen Inc Antagonistas y agonistas de ldcam y metodos para su uso.
WO2005059504A2 (fr) * 2003-12-12 2005-06-30 Bayer Healthcare Ag Diagnostics et therapeutique destines au traitement de maladies associees au recepteur couple aux proteines g gpr34 (gpr34)
DK2769729T3 (en) 2007-09-04 2019-04-23 Compugen Ltd POLYPEPTIDES AND POLYNUCLEOTIDES AND APPLICATIONS THEREOF AS A PHARMACEUTICAL OBJECTIVE FOR THE PRODUCTION OF MEDICINAL PRODUCTS AND BIOTECHNOLOGICAL PRODUCTS
SG188497A1 (en) 2010-09-22 2013-05-31 Alios Biopharma Inc Substituted nucleotide analogs
EP2726503B1 (fr) 2011-06-30 2019-09-04 Compugen Ltd. Polypeptides et leurs utilisations pour traiter les troubles auto-immuns et l'infection
CA2860234A1 (fr) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Analogues de nucleotide phosphorothioate substitue
CN104185681A (zh) 2012-02-01 2014-12-03 卡姆普根有限公司 C1orf32抗体及其用于治疗癌症的用途
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (fr) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Combinaisons pharmaceutiques comprenant un analogue thionucléotidique
SI3124976T1 (sl) * 2015-07-28 2018-12-31 F. Hoffmann-La Roche Ag Izboljšan test bakterijskih endotoksinov za določanje endotoksinov

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"GIBCO BRL, random primers DNA labeling system", GIBCO BRL CATALOG AND REFERENCE GUIDE, 1990, pages 404, XP002908340 *
DATABASE GENBANK [online] January 1999 (1999-01-01), YU ET AL.: "A novel endothelial cell-specific negative regulator of angiogenesis", XP002908339, accession no. NCBI Database accession no. AF039390 *
DATABASE GENBANK [online] July 2001 (2001-07-01), PLUMB B., XP002908338, Database accession no. AL390240 *

Also Published As

Publication number Publication date
WO2002026930A9 (fr) 2005-04-07
WO2002026930A2 (fr) 2002-04-04
AU2001296301A8 (en) 2009-07-30
AU2001296301A1 (en) 2002-04-08

Similar Documents

Publication Publication Date Title
WO2001055309A8 (fr) Acides nucleiques, proteines et anticorps
WO2001090304A3 (fr) Acides nucleiques, proteines et anticorps
WO2001054472A8 (fr) Acides nucleiques, proteines et anticorps
WO2001055306A3 (fr) Acides nucleiques, proteines, et anticorps
WO2001055326A8 (fr) Acides nucleiques, proteines et anticorps
WO2002026930A3 (fr) Acides nucleiques, proteines et anticorps
WO2001055440A8 (fr) Acides nucleiques, proteines et anticorps
WO2001055168A8 (fr) Acides nucleiques, proteines, et anticorps
WO2002072763A3 (fr) Acides nucleiques, proteines et anticorps
WO2001055167A8 (fr) Acides nucleiques, proteines et anticorps
WO2001055162A8 (fr) Acides nucleiques, proteines et anticorps
WO2001055449A8 (fr) Acides nucleiques, proteines et anticorps
WO2001055305A3 (fr) Acides nucleiques, proteines, et anticorps

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1-321, SEQUENCE LISTING, ADDED

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
COP Corrected version of pamphlet

Free format text: PAGES 1-321, SEQUENCE LISTING, ADDED

NENP Non-entry into the national phase

Ref country code: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)